These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27424890)

  • 61. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 62. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of poly(ethylene glycol) content and formulation parameters on particulate properties and intraperitoneal delivery of insulin from PLGA nanoparticles prepared using the double-emulsion evaporation procedure.
    Haggag YA; Faheem AM; Tambuwala MM; Osman MA; El-Gizawy SA; O'Hagan B; Irwin N; McCarron PA
    Pharm Dev Technol; 2018 Apr; 23(4):370-381. PubMed ID: 28285551
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA.
    Basarkar A; Devineni D; Palaniappan R; Singh J
    Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment.
    Saha C; Kaushik A; Das A; Pal S; Majumder D
    PLoS One; 2016; 11(5):e0155710. PubMed ID: 27196562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Applying Box-Behnken Design for Formulation and Optimization of PLGA-Coffee Nanoparticles and Detecting Enhanced Antioxidant and Anticancer Activities.
    Sharaf NS; Shetta A; Elhalawani JE; Mamdouh W
    Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012166
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
    Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
    Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Formulation and in vitro evaluation of niacin-loaded nanoparticles to reduce prostaglandin mediated vasodilatory flushing.
    Cooper DL; Carmical JA; Panus PC; Harirforoosh S
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(20):3977-88. PubMed ID: 26531288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of Poly(lactide-co-glicolide) Nanoparticles Incorporating Morphine Hydrochloride to Prolong its Circulation in Blood.
    Gomez-Murcia V; Montalban MG; Gomez-Fernandez JC; Almela P
    Curr Pharm Des; 2017; 23(13):2015-2025. PubMed ID: 27908267
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles.
    López-López M; Fernández-Delgado A; Moyá ML; Blanco-Arévalo D; Carrera C; de la Haba RR; Ventosa A; Bernal E; López-Cornejo P
    Pharmaceutics; 2019 Jan; 11(2):. PubMed ID: 30704034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation, Characterization and In vitro Evaluation of Insulin-PHBV Nanoparticles / Alginate Hydrogel Composite System for Prolonged Delivery of Insulin.
    Bayrami S; Chamani M; JamaliMoghadamSiahkali S; SeyedAlinaghi S; Shirmard LR; Bayrami S; Javar HA; Ghahremani MH; Amini M; Tehrani MR; Shahsavari S; Dorkoosh FA
    J Pharm Sci; 2024 Mar; ():. PubMed ID: 38508339
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polyhydroxyalkanoate Decelerates the Release of Paclitaxel from Poly(lactic-co-glycolic acid) Nanoparticles.
    Lee SY; Kim SY; Ku SH; Park EJ; Jang DJ; Kim ST; Kim SB
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015244
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimization and characterization of poly(lactic-co-glycolic acid) nanoparticles loaded with astaxanthin and evaluation of anti-photodamage effect
    Hu F; Liu W; Yan L; Kong F; Wei K
    R Soc Open Sci; 2019 Oct; 6(10):191184. PubMed ID: 31824727
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral Nanoformulations.
    Makita-Chingombe F; Kutscher HL; DiTursi SL; Morse GD; Maponga CC
    J Drug Deliv; 2016; 2016():3810175. PubMed ID: 27190651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design of expert guided investigation of native L-asparaginase encapsulated long-acting cross-linker-free poly (lactic-co-glycolic) acid nanoformulation in an Ehrlich ascites tumor model.
    Singh M; Hassan N; Verma D; Thakur P; Panda BP; Panda AK; Sharma RK; Mirza A; Mansoor S; Alrokayan SH; Khan HA; Ahmad P; Iqbal Z
    Saudi Pharm J; 2020 Jun; 28(6):719-728. PubMed ID: 32550804
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An Injectable Nano-Enabled Thermogel to Attain Controlled Delivery of p11 Peptide for the Potential Treatment of Ocular Angiogenic Disorders of the Posterior Segment.
    du Toit LC; Choonara YE; Pillay V
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33525495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.